Could diabetes drug Ozempic lower cancer risk? Here’s what a study finds – Khaleej Times
The researchers found that the patients who received a certain class of diabetes medications had a significantly lower risk of developing 10 out …
» Read moreThe researchers found that the patients who received a certain class of diabetes medications had a significantly lower risk of developing 10 out …
» Read moreGLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
» Read more… condition had not improved. A follow-up exam showed signs of kidney failure and signs of potential heart disease. Out of concern for Summer’s …
» Read moreA study has identified the ideal balance of daily sitting, standing and physical activity for optimal health. Peta Bee looks at how to get maximum …
» Read moreSanofi has received approval in Europe for the treatment of chronic obstructive pulmonary disease, COPD, with type 2 inflammation and chronic …
» Read moreHowever, increased preference for complementary and alternative medicine cam poses a challenge. Key market players include Abbott Laboratories …
» Read moreThis week, Diabetes Australia, the Australian Diabetes Society and the Australian Diabetes Educators Association welcomed recommendations from …
» Read moreCancer, on July 5th, 2024, you might find that your expenses outweigh your income, which could cause some financial strain.
» Read moreObjectiveDiabetes is a significant risk factor for acute heart failure, associated with an increased risk of mortality. This study aims to analyze …
» Read moreThe research team also simulates sweating and physical activity by having the test subjects walk around and do physical activities. “Because sweat …
» Read moreSimilarly, for obesity treatment, semaglutide users had a 6.7% incidence, compared to a much lower 0.8% with alternative drugs. Promoted. Listen to …
» Read more… chronic obstructive pulmonary disease (COPD) and type 2 inflammation. NOTUS aimed to replicate the findings from the BOREAS trial, which also …
» Read more